Diagnosing and Managing Steatotic Liver Disease
Metabolic dysfunction-associated steatotic liver disease is estimated to affect about 32.4% of the world’s population.
Read MorePosted by Chris Wolski | Nov 22, 2023 | Disease States |
Metabolic dysfunction-associated steatotic liver disease is estimated to affect about 32.4% of the world’s population.
Read MorePosted by Chris Wolski | Nov 16, 2023 | Diagnostic Technologies |
Consolidation, legislation, new testing types, and a shift to more consumer-driven testing are some clinical laboratory predictions for 2024.
Read MorePosted by Andy Lundin | Nov 9, 2023 | Miscellaneous, Sample Storage & Management |
Quest Mobile is a service designed to make it easier and more convenient for patients to have a specimen collected for lab testing nationwide.
Read MorePosted by Andy Lundin | Nov 8, 2023 | Diabetes & Metabolic Diseases |
Researchers show that patients with central diabetes insipidus who lack anti-rabphilin-3A antibodies could be at risk of tumor development
Read MorePosted by Andy Lundin | Nov 3, 2023 | Kidney Disease |
Investigators developed an automated health maintenance tool to prompt physicians to screen for chronic kidney disease in diabetes patients.
Read More